Quick Answer
CAPRICOR THERAPEUTICS, INC. reported Total Assets of $355.95 million for fiscal year 2025.
CAPRICOR THERAPEUTICS, INC. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $355.95M | +108.8% |
| 2024 | $170.48M | +190.3% |
| 2023 | $58.73M | +17.2% |
| 2022 | $50.09M | +21.2% |
| 2021 | $41.33M | +19.4% |
| 2020 | $34.62M | +211.5% |
| 2019 | $11.11M | +20.2% |
| 2018 | $9.25M | -43.2% |
| 2017 | $16.27M | -13.2% |
| 2016 | $18.75M | +16.7% |
| 2015 | $16.07M | +17.9% |
| 2014 | $13.63M | +146.2% |
| 2013 | $5.54M | +2.1% |
| 2012 | $5.42M | +295.3% |
| 2011 | $1.37M | -62.6% |
| 2010 | $3.67M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $126.44M | +36.0% | -5.3% |
| June 30, 2025 | $133.57M | +248.9% | -13.1% |
| March 31, 2025 | $153.77M | +211.0% | -9.8% |
| December 31, 2024 | $170.48M | +190.3% | +83.4% |
| September 30, 2024 | $92.95M | +150.2% | +142.8% |
| June 30, 2024 | $38.28M | -16.8% | -22.6% |
| March 31, 2024 | $49.44M | -8.2% | -15.8% |
| December 31, 2023 | $58.73M | +17.2% | +58.1% |
- CAPRICOR THERAPEUTICS, INC. showed an increase of +108.8% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, CAPRICOR THERAPEUTICS, INC.’s total assets has grown by 9609.6% (from $3.67 million to $355.95 million).
- The most recent figure is from CAPRICOR THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: